Financial Strains, Therapeutic Pauses, and Tributes

This chapter covers GM's financial concerns due to tariffs and their strategies to mitigate costs. It also highlights Sarepta Therapeutics' pause on a gene therapy shipment following FDA concerns and pays tribute to a beloved actor's legacy, exploring themes of acceptance and love.